Paroxetine Hydrochloride
Spezifikationen
78246-49-8CAS-Nummer
616-601-1EG-Nummer
(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine;hydrochlorideIUPAC-Name
C19H21ClFNO3Chemische Formel
365.8 g/molMolekulargewicht
Paroxetine hydrochloride; 78246-49-8; Paroxetine Hcl; Paroxat; Paxil CR; 3I3T11UD2S; Paroxetine hydrochloride [USP]; Paroxetine Hydrochloride Anhydrous; NSC-758654; BRL29060A; CHEBI:7944; Paroxetine hydrochloride (USP); DTXSID50228914; Deroxat; Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride, (3S,4R)-; Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride, (3S-trans)-; Paxilcr CR; RefChem:858692; DTXCID00151405; (-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine Hydrochloride; X2ELS050D8; Seroxat; Paxil; (3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine hydrochloride; paroxetine (hydrochloride); C19H21ClFNO3; MFCD00797405; 5V22ESA4MA; Paroxetine hydrochloride hemihydrate (MW = 374.83); Paroxetine hydrochloride, (+/-)-; (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine;hydrochloride; Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride (1:1), (3S,4R)-; Paroxetine hydrochloride, trans-(+/-)-; Paxil (TN); (-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)-methyl)piperidine hydrochloride; Aropax 20; CHEMBL1708; MFCD03658863; 130855-16-2; (3S,4R)-3-[(Benzo[d][1,3]dioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride; BRL 29060 hydrochloride; Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride, trans-; trans-(+/-)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine hydrochloride; Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride (1:1), (3R,4S)-rel-; Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride, (3R,4S)-rel-; Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride, trans-(+/-)-; BRL 29060A; SDB 7175; UNII-3I3T11UD2S; S3005; UNII-5V22ESA4MA; Paroxetine Impurity Standard; SCHEMBL33348; (-)-Paroxetine hydrochloride; Paroxetine HCl (hemihydrate); MLS002222322; SPECTRUM1504085; orb1224008; orb1307940; SCHEMBL29437926; HY-B0492R; GLXC-04133; HMS1922B11; Pharmakon1600-01504085; (-)-trans-paroxetine hydrochloride; HY-B0492; MSK10675; Tox21_500095; CCG-39866; EBC-12122; HB0478; NSC758654; AKOS015849162; AKOS015907108; Paroxetine (hydrochloride) (Standard); FP38223; FP60426; KS-5097; LP00095; NSC 758654; (3S,4R)-3-[(2H-1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride; Paroxetine hydrochloride [EP monograph]; NCGC00093597-01; NCGC00260780-01; Paroxetine hydrochloride (anhydrous) CRS; PAROXETINE HYDROCHLORIDE [WHO-DD]; BP164263; PAROXETINE HYDROCHLORIDE, ANHYDROUS; SMR001307264; SY105826; EU-0100095; P1977; SW197457-4; T1636; D05374; D70630; EN300-124073; Paroxetine HCl hemihydrate - Bio-X trade mark; PAROXETINE HYDROCHLORIDE ANHYDROUS [MI]; SR-01000759305; SR-01000759305-6; Q27257245; Z1557492145; (-)-trans-4-(-4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-piperidine hydrochloride; (-)-trans-4-(-4-fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)-piperidine hydrochloride; (-)-trans-4-(4-fluorophenyl)-3-(3,4-methylene dioxyphenoxymethyl)-piperidine hydrochloride; (3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidinehydrochloride; (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride; (3S,4R)-3-[(1,3-dioxaindan-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride; (3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-piperidine hydrochloride; (3S,4R)-(-)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride; (3S,4R)-(-)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride Hemihydrate; (3S,4R)-3-{[(2H-1,3-Benzodioxol-5-yl)oxy]methyl}-4-(4-fluorophenyl)piperidine--hydrogen chloride (1/1); Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, (3S,4R)-, hydrochloride (1:1); Anhydrous Paroxetine Hydrochloride; Paroxetine HCl anhydrousSynonyme
Produkte, die Paroxetine Hydrochloride enthalten
산도스파록세틴정(무수염산파록세틴)PAROXETINA VIR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGPAROXETINA TEVA-RATIO 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGPAROXETINA TEVA-RATIO 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGPAROXETINA TEVA-RATIO 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGPAROXETINA TARBIS 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGPAROXETINA QUALIGEN FARMA 20 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGPAROXETINA PENSA 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGPAROXETINA MABO 40 mg COMPRIMIDOSPAROXETINA MABO 30 mg COMPRIMIDOSPAROXETINA MABO 20 mg COMPRIMIDOS EFGPAROXETINA MABO 10 mg COMPRIMIDOS EFG
Seite 1 von 5
Unternehmen, die Paroxetine Hydrochloride verkaufen
삼일
삼일제약(주)Republic of KoreaSI
Sinoway Industrial Co.Ltd.ChinaSeite 1 von 3